TEAM

Co-founders, William and Antti, are true visionaries who together combine strong operational skills with extensive entrepreneurial experience. The science team is world-class with experience from the most prestigious academic institutions in the world. The combination of people is unique and enables the company to focus on the hardest problems in biotech. 

PROBLEM

Traditionally, diagnosing cancer in dogs almost always happens too late, which leaves very few and poor treatment options. Over 10 million dogs die of cancer annually.

SOLUTION

DeepScan has developed a comprehensive cancer test capable of detecting the most prevalent cancers in dogs months before clinical signals are shown, thereby significantly improving treatment outcomes. DeepScan's tests are sold at veterinary clinics as part of yearly health checks or as standalone tests. In the future the company plans to expand its portfolio of tests.

‍